Company

Eli Lilly and Co

NYSE:LLY

Eli Lilly and Co is engaged in drug manufacturing businesses. The company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. 

147 stories · page 2 of 8

Pharma & Biotech

Eli Lilly cuts price of Zepbound in heightened weight-loss drug competition

By Proactive 01/12/2025

Pharma & Biotech

Eli Lilly first healthcare company to hit $1T market capitalization

By Proactive 21/11/2025

Pharma & Biotech

Eli Lilly Q3 earnings and revenue top estimates, boosted by weight loss drug demand

By Proactive 30/10/2025

Pharma & Biotech

Eli Lilly Q3 earnings eyed for insights into drug pricing policies

By Proactive 20/10/2025

Pharma & Biotech

Prospect of daily weight loss pill moves closer after Lily trial success

By Proactive 17/09/2025

Pharma & Biotech

Eli Lilly launches AI platform for drug discovery

By Proactive 09/09/2025

Pharma & Biotech

Eli Lilly halts UK shipments of Mounjaro diabetes and weight-loss drug

By Proactive 28/08/2025

Pharma & Biotech

Eli Lilly advances weight loss pill towards regulatory submissions after successful trial

By Proactive 26/08/2025

Pharma & Biotech

Eli Lilly to hike UK price of weight-loss drug Mounjaro

By Proactive 15/08/2025

Pharma & Biotech

Eli Lilly shares tumble on disappointing weight loss drug trial data

By Proactive 07/08/2025

Pharma & Biotech

Eli Lilly Q2 preview: BofA sees focus on policy risks, obesity pipeline

By Proactive 09/07/2025

Pharma & Biotech

Eli Lilly lining up $1.3bn swoop for cholesterol specialist Verve

By Proactive 17/06/2025

Pharma & Biotech

Eli Lilly expands neuroscience pipeline with $1B SiteOne acquisition

By Proactive 27/05/2025

Pharma & Biotech

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in obesity drug trial

By Proactive 12/05/2025

Pharma & Biotech

Eli Lilly shares slide despite weight-loss drug boost as company trims 2025 profit outlook

By Proactive 01/05/2025

Pharma & Biotech

Eli Lilly shares surge on strong trial results for weight-loss pill

By Proactive 17/04/2025

Pharma & Biotech

Is Ozempic maker Novo Nordisk losing to Eli Lilly in the obesity wars?

By Proactive 24/03/2025

Pharma & Biotech

Eli Lilly announces $27B investment in US drug manufacturing

By Proactive 26/02/2025

Pharma & Biotech

Eli Lilly introduces new doses of weight loss drug Zepbound at discounted prices

By Proactive 25/02/2025

Pharma & Biotech

Eli Lilly revenue misses expectations despite strong growth in Mounjaro, Zepbound

By Proactive 06/02/2025